via Novartis (NVS) released its Q2 2018 earnings on July 18 and surpassed Wall Street analysts’ estimates for revenues and EPS. It reported revenues of $13.2 billion and EPS of $1.29, which compares to the estimated EPS of $1.28 on revenues of $13 billion. article source